Grey Wolf Health Corp. WOLF.V
TSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 11.01% | 15.61% | 34.88% | 34.02% | 30.87% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 11.01% | 15.61% | 34.88% | 34.02% | 30.87% |
| Cost of Revenue | 11.75% | 12.09% | 30.36% | 29.08% | 21.82% |
| Gross Profit | 10.43% | 18.78% | 39.35% | 38.79% | 39.06% |
| SG&A Expenses | 23.97% | 21.12% | 5.53% | 29.86% | 32.29% |
| Depreciation & Amortization | 0.24% | -9.58% | 35.05% | 81.97% | 74.27% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 16.19% | 14.32% | 19.09% | 31.65% | 28.25% |
| Operating Income | -16.35% | 32.21% | 685.70% | 51.12% | 46.71% |
| Income Before Tax | -23.88% | 250.18% | 198.10% | 12.86% | 15.86% |
| Income Tax Expenses | -1.35% | 143.78% | -2.21% | 23.11% | -6.76% |
| Earnings from Continuing Operations | -33.11% | 457.37% | 165.98% | 8.26% | 28.64% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -33.11% | 457.37% | 165.98% | 8.26% | 28.64% |
| EBIT | -16.35% | 32.21% | 685.70% | 51.12% | 46.71% |
| EBITDA | -13.97% | 12.98% | 369.29% | 62.03% | 58.60% |
| EPS Basic | -33.96% | 416.67% | 150.35% | -1.68% | 16.91% |
| Normalized Basic EPS | -25.00% | 260.00% | 174.67% | 2.80% | 5.26% |
| EPS Diluted | -33.96% | 383.33% | 135.43% | -1.68% | 16.91% |
| Normalized Diluted EPS | -25.00% | 250.00% | 174.67% | -0.93% | 5.26% |
| Average Basic Shares Outstanding | 0.95% | 0.58% | 31.42% | 10.18% | 10.18% |
| Average Diluted Shares Outstanding | 0.95% | 1.20% | 31.42% | 14.71% | 10.18% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |